{"id":68412,"date":"2026-09-07T10:14:47","date_gmt":"2026-09-07T04:44:47","guid":{"rendered":"https:\/\/higujarat.com\/index.php\/2026\/09\/07\/sudarshan-pharma-industries-to-acquire-9-5-stake-in-us-based-medtherapy-biotech\/"},"modified":"2026-09-07T10:14:47","modified_gmt":"2026-09-07T04:44:47","slug":"sudarshan-pharma-industries-to-acquire-9-5-stake-in-us-based-medtherapy-biotech","status":"publish","type":"post","link":"https:\/\/higujarat.com\/index.php\/2026\/09\/07\/sudarshan-pharma-industries-to-acquire-9-5-stake-in-us-based-medtherapy-biotech\/","title":{"rendered":"Sudarshan Pharma Industries to Acquire 9.5% Stake in US-Based MedTherapy Biotech"},"content":{"rendered":"<p class=\"wp-block-paragraph\"><strong>Mumbai (Maharashtra) [India], September 7:<\/strong> BSE-listed\u00a0Sudarshan Pharma Industries Ltd [BSE Scrip Code: 543828, Trading Symbol: SUDARSHAN, ISIN: INE00TV01023]\u00a0has announced its first major overseas biotech acquisition.<\/p>\n<p class=\"wp-block-paragraph\">In a disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company informed exchanges that its Board of Directors at its meeting held today &#8211; 5th September 2026 between 4:30 pm and 5:00 pm &#8211; has approved the acquisition of&nbsp;24,23,675.64 equity shares&nbsp;of Common Stock, par value US$0.0001 per share, of&nbsp;MedTherapy Biotechnology Inc., USA.<\/p>\n<p class=\"wp-block-paragraph\">The acquisition represents&nbsp;9.50% of the issued and outstanding share capital&nbsp;of the target company. The consideration will be paid in cash in US Dollars, with the price based on valuation as per prevailing valuation norms.<\/p>\n<h3 class=\"wp-block-heading\">Promoters to co-invest<\/h3>\n<p class=\"wp-block-paragraph\">Alongside the company, its promoters will also acquire a stake in the same target:<\/p>\n<ul class=\"wp-block-list\">\n<li>Mr. Hemal Mehta, Chairman &amp; Managing Director:\u00a03,82,685.63 shares (1.50%)<\/li>\n<li>Mr. Sachin Mehta, Joint Managing Director:\u00a03,82,685.63 shares (1.50%)<\/li>\n<\/ul>\n<p class=\"wp-block-paragraph\">The company clarified that the transaction does not fall within related party transactions and will be done at arm&#8217;s length.<\/p>\n<p class=\"wp-block-paragraph\">Legal and commercial due diligence will be concluded before closure, with FEMA compliances to be addressed.<\/p>\n<h3 class=\"wp-block-heading\">Target Snapshot: MedTherapy Biotechnology Inc.<\/h3>\n<p class=\"wp-block-paragraph\">According to Annexure-A filed by the company:<\/p>\n<p class=\"wp-block-paragraph\">Name:&nbsp;MedTherapy Biotechnology Inc. (&#8220;MedTherapy Biotech&#8221;), a corporation incorporated under the laws of the State of Delaware, USA<\/p>\n<p class=\"wp-block-paragraph\">Business:&nbsp;Boston-based global Cancer Cell &amp; Gene Therapy Company founded in 2018 by experts from Harvard and former Novartis executives. It operates as an end-to-end, integrated CAR-T Cell CDMO, with a commercial-scale GMP manufacturing facility in New Delhi, India and a technology development site in Boston, USA.<\/p>\n<p class=\"wp-block-paragraph\">Mission:&nbsp;Founded with a mission to make CAR-T cell therapy affordable and accessible so that almost every cancer patient would be able to afford it.<\/p>\n<h3 class=\"wp-block-heading\">Strategic Rationale<\/h3>\n<p class=\"wp-block-paragraph\">Sudarshan Pharma listed three key objects for the 9.5% acquisition:<\/p>\n<ol class=\"wp-block-list\">\n<li>Enter the U.S. market and establish a presence there.<\/li>\n<li>Access the customer base, contracts, and distribution network.<\/li>\n<li>Expand into new products and services.<\/li>\n<\/ol>\n<p class=\"wp-block-paragraph\">The move marks a diversification beyond its main line of business into high-value advanced cell and gene therapy CDMO services.<\/p>\n<h3 class=\"wp-block-heading\">Regulatory Path &amp; Timeline<\/h3>\n<p class=\"wp-block-paragraph\">The company said governmental approval required is from the&nbsp;Reserve Bank of India under Foreign Exchange Management Act, 1999&nbsp;and the Foreign Exchange Management (Overseas Investment) Rules, Regulations and Directions, 2022, as may be amended from time to time &#8211; under the automatic route.<\/p>\n<p class=\"wp-block-paragraph\">Indicative time period for completion:&nbsp;On or before&nbsp;31st March 2027.<\/p>\n<p class=\"wp-block-paragraph\">The company has requested BSE to take the disclosure on record.<\/p>\n<p class=\"wp-block-paragraph\">\n","protected":false},"excerpt":{"rendered":"<p>Mumbai (Maharashtra) [India], September 7: BSE-listed\u00a0Sudarshan Pharma Industries Ltd [BSE Scrip Code: 543828, Trading Symbol: SUDARSHAN, ISIN: INE00TV01023]\u00a0has announced its first major overseas biotech acquisition. In a disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company informed exchanges that its Board of Directors at its meeting held today &#8211;&#8230;<\/p>\n","protected":false},"author":1,"featured_media":68411,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[],"class_list":["post-68412","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business"],"_links":{"self":[{"href":"https:\/\/higujarat.com\/index.php\/wp-json\/wp\/v2\/posts\/68412","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/higujarat.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/higujarat.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/higujarat.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/higujarat.com\/index.php\/wp-json\/wp\/v2\/comments?post=68412"}],"version-history":[{"count":0,"href":"https:\/\/higujarat.com\/index.php\/wp-json\/wp\/v2\/posts\/68412\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/higujarat.com\/index.php\/wp-json\/wp\/v2\/media\/68411"}],"wp:attachment":[{"href":"https:\/\/higujarat.com\/index.php\/wp-json\/wp\/v2\/media?parent=68412"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/higujarat.com\/index.php\/wp-json\/wp\/v2\/categories?post=68412"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/higujarat.com\/index.php\/wp-json\/wp\/v2\/tags?post=68412"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}